Integrating mass spectrometry and genomics for cyanobacterial metabolite discovery

Abstract excerpt

Filamentous marine cyanobacteria produce bioactive natural products with both potential therapeutic value and capacity to be harmful to human health. Genome sequencing has revealed that cyanobacteria have the capacity to produce many more secondary metabolites than have been characterized. The biosynthetic pathways that encode cyanobacterial natural products are mostly uncharacterized, and lack of cyanobacterial...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Metabolomics and Mass Spectrometry Studies
• Share to Microbial Natural Products and Biosynthesis